logo

For the Inventor, By the Inventor

South San Francisco, CA, United States of America

Gang Yin

USPTO Granted Patents = 19 

 

Average Co-Inventor Count = 4.9

ph-index = 4

Forward Citations = 53(Granted Patents)


Company Filing History:

goldMedal18 out of 52 
 
Sutro Biopharma, Inc.
 patents
silverMedal1 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents

Years Active: 2014-2025

Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents
1. 12427201 - Anti-folate receptor antibody conjugates, compositions comprising anti-folate receptor antibody conjugates, and methods of making and using anti-folate receptor antibody conjugates (2025-09-30),
2. 12398197 - Antibodies with engineered CH2 domains, compositions thereof and methods of using the same (2025-08-26),
3. 12252552 - Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use (2025-03-18),
4. 12226490 - Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugates preliminary class (2025-02-18),
5. 12144869 - Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugates (2024-11-19),
6. 12071477 - Anti-folate receptor alpha antibody conjugated with hemiasterlins (2024-08-27),
7. 11958909 - Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use (2024-04-16),
8. 11827684 - Human interleukin-2 conjugates biased for the interleukin-2 receptor beta GAMMAc dimer and conjugated to a nonpeptidic, water-soluble polymer (2023-11-28),
9. 11744876 - Immunomodulator antibody drug conjugates and uses thereof (2023-09-05),
10. 11344626 - Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use (2022-05-31),
11. 11098107 - Antibodies with engineered CH2 domains, compositions thereof and methods of using the same (2021-08-24),
12. 10669347 - Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use (2020-06-02),
13. 10596270 - Anti-folate receptor antibody conjugates, compositions comprising anti-folate receptor antibody conjugates, and methods of making and using anti-folate receptor antibody conjugates (2020-03-24),
14. 10501558 - Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use (2019-12-10),
15. 10487133 - Codon optimization for titer and fidelity improvement (2019-11-26),

Title: Inventor Gang Yin: Pioneering Innovations in South San Francisco

Introduction: Gang Yin is a visionary inventor based in South San Francisco, CA, known for his groundbreaking contributions to the field of technology and beyond.

Latest Patents: Gang Yin holds several patents in various industries, including biotechnology, artificial intelligence, and renewable energy. His most recent patents focus on sustainable solutions for urban development and healthcare advancements.

Career Highlights: With a career spanning over two decades, Gang Yin has worked with leading research institutions and tech companies to bring his ideas to life. His innovative approach to problem-solving has led to significant advancements in multiple sectors.

Collaborations: Gang Yin has collaborated with top universities and multinational corporations to further develop his inventions. His partnerships have resulted in cutting-edge technologies that have the potential to shape the future of various industries.

Conclusion: Gang Yin's passion for innovation and his relentless drive to create a positive impact on society make him a true pioneer in the world of inventions. His work continues to inspire and pave the way for future generations of inventors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…